Logo image of HLF

HERBALIFE LTD (HLF) Stock Fundamental Analysis

USA - NYSE:HLF - KYG4412G1010 - Common Stock

9.28 USD
-0.03 (-0.32%)
Last: 9/18/2025, 8:04:00 PM
9.28 USD
0 (0%)
After Hours: 9/18/2025, 8:04:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to HLF. HLF was compared to 36 industry peers in the Personal Care Products industry. HLF has an excellent profitability rating, but there are concerns on its financial health. HLF scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year HLF was profitable.
HLF had a positive operating cash flow in the past year.
Each year in the past 5 years HLF has been profitable.
Each year in the past 5 years HLF had a positive operating cash flow.
HLF Yearly Net Income VS EBIT VS OCF VS FCFHLF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

1.2 Ratios

The Return On Assets of HLF (11.88%) is better than 83.33% of its industry peers.
HLF's Return On Invested Capital of 26.65% is amongst the best of the industry. HLF outperforms 94.44% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for HLF is significantly above the industry average of 12.97%.
The last Return On Invested Capital (26.65%) for HLF is above the 3 year average (21.47%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 11.88%
ROE N/A
ROIC 26.65%
ROA(3y)8.71%
ROA(5y)10.82%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)21.47%
ROIC(5y)23.4%
HLF Yearly ROA, ROE, ROICHLF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

1.3 Margins

HLF has a better Profit Margin (6.59%) than 75.00% of its industry peers.
HLF's Profit Margin has declined in the last couple of years.
The Operating Margin of HLF (12.68%) is better than 77.78% of its industry peers.
HLF's Operating Margin has declined in the last couple of years.
With an excellent Gross Margin value of 78.12%, HLF belongs to the best of the industry, outperforming 91.67% of the companies in the same industry.
HLF's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 12.68%
PM (TTM) 6.59%
GM 78.12%
OM growth 3Y-9.16%
OM growth 5Y-4.06%
PM growth 3Y-12.9%
PM growth 5Y-4.4%
GM growth 3Y-0.32%
GM growth 5Y-0.62%
HLF Yearly Profit, Operating, Gross MarginsHLF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

3

2. Health

2.1 Basic Checks

HLF has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for HLF has been increased compared to 1 year ago.
The number of shares outstanding for HLF has been reduced compared to 5 years ago.
HLF has a better debt/assets ratio than last year.
HLF Yearly Shares OutstandingHLF Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
HLF Yearly Total Debt VS Total AssetsHLF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

HLF has an Altman-Z score of 2.37. This is not the best score and indicates that HLF is in the grey zone with still only limited risk for bankruptcy at the moment.
HLF has a Altman-Z score (2.37) which is in line with its industry peers.
HLF has a debt to FCF ratio of 12.49. This is a negative value and a sign of low solvency as HLF would need 12.49 years to pay back of all of its debts.
HLF has a Debt to FCF ratio of 12.49. This is comparable to the rest of the industry: HLF outperforms 55.56% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 12.49
Altman-Z 2.37
ROIC/WACC3.8
WACC7.01%
HLF Yearly LT Debt VS Equity VS FCFHLF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

2.3 Liquidity

A Current Ratio of 1.01 indicates that HLF should not have too much problems paying its short term obligations.
With a Current ratio value of 1.01, HLF is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
HLF has a Quick Ratio of 1.01. This is a bad value and indicates that HLF is not financially healthy enough and could expect problems in meeting its short term obligations.
HLF has a worse Quick ratio (0.54) than 80.56% of its industry peers.
Industry RankSector Rank
Current Ratio 1.01
Quick Ratio 0.54
HLF Yearly Current Assets VS Current LiabilitesHLF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 7.65% over the past year.
Measured over the past years, HLF shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.08% on average per year.
HLF shows a decrease in Revenue. In the last year, the revenue decreased by -2.25%.
Measured over the past years, HLF shows a small growth in Revenue. The Revenue has been growing by 0.47% on average per year.
EPS 1Y (TTM)7.65%
EPS 3Y-25.39%
EPS 5Y-7.08%
EPS Q2Q%9.26%
Revenue 1Y (TTM)-2.25%
Revenue growth 3Y-4.89%
Revenue growth 5Y0.47%
Sales Q2Q%-1.72%

3.2 Future

Based on estimates for the next years, HLF will show a very strong growth in Earnings Per Share. The EPS will grow by 21.90% on average per year.
Based on estimates for the next years, HLF will show a small growth in Revenue. The Revenue will grow by 3.70% on average per year.
EPS Next Y9.81%
EPS Next 2Y16.97%
EPS Next 3Y21.9%
EPS Next 5YN/A
Revenue Next Year0.28%
Revenue Next 2Y2.38%
Revenue Next 3Y3.7%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
HLF Yearly Revenue VS EstimatesHLF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B 5B
HLF Yearly EPS VS EstimatesHLF Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

9

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 4.40, which indicates a rather cheap valuation of HLF.
Based on the Price/Earnings ratio, HLF is valued cheaper than 100.00% of the companies in the same industry.
HLF's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.41.
A Price/Forward Earnings ratio of 3.46 indicates a rather cheap valuation of HLF.
Based on the Price/Forward Earnings ratio, HLF is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
HLF is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.88, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 4.4
Fwd PE 3.46
HLF Price Earnings VS Forward Price EarningsHLF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

HLF's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. HLF is cheaper than 97.22% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, HLF is valued cheaper than 97.22% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.58
EV/EBITDA 3.73
HLF Per share dataHLF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30 40

4.3 Compensation for Growth

HLF's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of HLF may justify a higher PE ratio.
A more expensive valuation may be justified as HLF's earnings are expected to grow with 21.90% in the coming years.
PEG (NY)0.45
PEG (5Y)N/A
EPS Next 2Y16.97%
EPS Next 3Y21.9%

0

5. Dividend

5.1 Amount

No dividends for HLF!.
Industry RankSector Rank
Dividend Yield N/A

HERBALIFE LTD

NYSE:HLF (9/18/2025, 8:04:00 PM)

After market: 9.28 0 (0%)

9.28

-0.03 (-0.32%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)10-28 2025-10-28/amc
Inst Owners105.01%
Inst Owner Change-2.25%
Ins Owners2.11%
Ins Owner Change0.5%
Market Cap956.86M
Analysts50.91
Price Target9.52 (2.59%)
Short Float %11.15%
Short Ratio6.03
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)55.95%
Min EPS beat(2)52.72%
Max EPS beat(2)59.17%
EPS beat(4)4
Avg EPS beat(4)58.76%
Min EPS beat(4)52.72%
Max EPS beat(4)62.26%
EPS beat(8)6
Avg EPS beat(8)34.13%
EPS beat(12)9
Avg EPS beat(12)27.43%
EPS beat(16)12
Avg EPS beat(16)24.72%
Revenue beat(2)0
Avg Revenue beat(2)-1.59%
Min Revenue beat(2)-1.94%
Max Revenue beat(2)-1.24%
Revenue beat(4)1
Avg Revenue beat(4)-1.04%
Min Revenue beat(4)-1.94%
Max Revenue beat(4)0.12%
Revenue beat(8)3
Avg Revenue beat(8)-0.88%
Revenue beat(12)6
Avg Revenue beat(12)-0.02%
Revenue beat(16)7
Avg Revenue beat(16)-0.19%
PT rev (1m)3.7%
PT rev (3m)16.67%
EPS NQ rev (1m)-15.66%
EPS NQ rev (3m)-16.99%
EPS NY rev (1m)1.04%
EPS NY rev (3m)1.04%
Revenue NQ rev (1m)0.71%
Revenue NQ rev (3m)2.15%
Revenue NY rev (1m)0.62%
Revenue NY rev (3m)0.92%
Valuation
Industry RankSector Rank
PE 4.4
Fwd PE 3.46
P/S 0.19
P/FCF 5.58
P/OCF 3.61
P/B N/A
P/tB N/A
EV/EBITDA 3.73
EPS(TTM)2.11
EY22.74%
EPS(NY)2.68
Fwd EY28.9%
FCF(TTM)1.66
FCFY17.91%
OCF(TTM)2.57
OCFY27.73%
SpS47.8
BVpS-6.41
TBVpS-10.45
PEG (NY)0.45
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 11.88%
ROE N/A
ROCE 38.05%
ROIC 26.65%
ROICexc 33.13%
ROICexgc 48.44%
OM 12.68%
PM (TTM) 6.59%
GM 78.12%
FCFM 3.48%
ROA(3y)8.71%
ROA(5y)10.82%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)21.47%
ROIC(5y)23.4%
ROICexc(3y)31.31%
ROICexc(5y)37.76%
ROICexgc(3y)50.31%
ROICexgc(5y)62.7%
ROCE(3y)30.65%
ROCE(5y)33.4%
ROICexcg growth 3Y-11.83%
ROICexcg growth 5Y-10.42%
ROICexc growth 3Y-12.15%
ROICexc growth 5Y-7.63%
OM growth 3Y-9.16%
OM growth 5Y-4.06%
PM growth 3Y-12.9%
PM growth 5Y-4.4%
GM growth 3Y-0.32%
GM growth 5Y-0.62%
F-Score6
Asset Turnover1.8
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 12.49
Debt/EBITDA 2.65
Cap/Depr 77.73%
Cap/Sales 1.91%
Interest Coverage 250
Cash Conversion 35.59%
Profit Quality 52.74%
Current Ratio 1.01
Quick Ratio 0.54
Altman-Z 2.37
F-Score6
WACC7.01%
ROIC/WACC3.8
Cap/Depr(3y)118.39%
Cap/Depr(5y)121.51%
Cap/Sales(3y)2.71%
Cap/Sales(5y)2.55%
Profit Quality(3y)93.92%
Profit Quality(5y)97.9%
High Growth Momentum
Growth
EPS 1Y (TTM)7.65%
EPS 3Y-25.39%
EPS 5Y-7.08%
EPS Q2Q%9.26%
EPS Next Y9.81%
EPS Next 2Y16.97%
EPS Next 3Y21.9%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.25%
Revenue growth 3Y-4.89%
Revenue growth 5Y0.47%
Sales Q2Q%-1.72%
Revenue Next Year0.28%
Revenue Next 2Y2.38%
Revenue Next 3Y3.7%
Revenue Next 5YN/A
EBIT growth 1Y53.68%
EBIT growth 3Y-13.6%
EBIT growth 5Y-3.61%
EBIT Next Year37.68%
EBIT Next 3Y19.2%
EBIT Next 5YN/A
FCF growth 1Y9.94%
FCF growth 3Y-19.13%
FCF growth 5Y-14.2%
OCF growth 1Y-13.02%
OCF growth 3Y-14.73%
OCF growth 5Y-9.01%